These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 26826462

  • 21. Genetics and outcome of atypical hemolytic-uremic syndrome in Turkish children: a retrospective study between 2010 and 2017, a single-center experience.
    Conkar S, Mir S, Berdeli A.
    Iran J Kidney Dis; 2019 Sep; 13(5):316-321. PubMed ID: 31705748
    [Abstract] [Full Text] [Related]

  • 22. Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation.
    Matsumoto T, Fan X, Ishikawa E, Ito M, Amano K, Toyoda H, Komada Y, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Fujimura Y, Ikejiri M, Wada H, Miyata T.
    Int J Hematol; 2014 Nov; 100(5):437-42. PubMed ID: 25135378
    [Abstract] [Full Text] [Related]

  • 23. A complement factor B mutation in a large kindred with atypical hemolytic uremic syndrome.
    Funato M, Uemura O, Ushijima K, Ohnishi H, Orii K, Kato Z, Yamakawa S, Nagai T, Ohara O, Kaneko H, Kondo N.
    J Clin Immunol; 2014 Aug; 34(6):691-5. PubMed ID: 24906628
    [Abstract] [Full Text] [Related]

  • 24. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
    Moore I, Strain L, Pappworth I, Kavanagh D, Barlow PN, Herbert AP, Schmidt CQ, Staniforth SJ, Holmes LV, Ward R, Morgan L, Goodship TH, Marchbank KJ.
    Blood; 2010 Jan 14; 115(2):379-87. PubMed ID: 19861685
    [Abstract] [Full Text] [Related]

  • 25. Complete functional characterization of disease-associated genetic variants in the complement factor H gene.
    Merinero HM, García SP, García-Fernández J, Arjona E, Tortajada A, Rodríguez de Córdoba S.
    Kidney Int; 2018 Feb 14; 93(2):470-481. PubMed ID: 28941939
    [Abstract] [Full Text] [Related]

  • 26. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.
    Le Quintrec M, Zuber J, Moulin B, Kamar N, Jablonski M, Lionet A, Chatelet V, Mousson C, Mourad G, Bridoux F, Cassuto E, Loirat C, Rondeau E, Delahousse M, Frémeaux-Bacchi V.
    Am J Transplant; 2013 Mar 14; 13(3):663-75. PubMed ID: 23356914
    [Abstract] [Full Text] [Related]

  • 27. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V, Gupta M, Elrifai M, Moftakhar B, Ensley MJ, Vachharajani TJ, Sethi SK, Raina R.
    Ther Apher Dial; 2018 Apr 14; 22(2):178-188. PubMed ID: 29250893
    [Abstract] [Full Text] [Related]

  • 28. The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome.
    Martinez-Barricarte R, Pianetti G, Gautard R, Misselwitz J, Strain L, Fremeaux-Bacchi V, Skerka C, Zipfel PF, Goodship T, Noris M, Remuzzi G, de Cordoba SR, European Working Party on the Genetics of HUS.
    J Am Soc Nephrol; 2008 Mar 14; 19(3):639-46. PubMed ID: 18235085
    [Abstract] [Full Text] [Related]

  • 29. A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic syndrome.
    Tawadrous H, Maga T, Sharma J, Kupferman J, Smith RJ, Schoeneman M.
    Pediatr Nephrol; 2010 May 14; 25(5):947-51. PubMed ID: 20108004
    [Abstract] [Full Text] [Related]

  • 30. Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.
    Volokhina E, Westra D, Xue X, Gros P, van de Kar N, van den Heuvel L.
    Pediatr Nephrol; 2012 Sep 14; 27(9):1519-24. PubMed ID: 22669319
    [Abstract] [Full Text] [Related]

  • 31. Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.
    Esparza-Gordillo J, Jorge EG, Garrido CA, Carreras L, López-Trascasa M, Sánchez-Corral P, de Córdoba SR.
    Mol Immunol; 2006 Apr 14; 43(11):1769-75. PubMed ID: 16386793
    [Abstract] [Full Text] [Related]

  • 32. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D, Yu XJ, Wang FM, Xu BN, He YD, Chen Q, Wang SX, Yu F, Song WC, Zhao MH.
    Am J Reprod Immunol; 2015 Oct 14; 74(4):345-56. PubMed ID: 26011580
    [Abstract] [Full Text] [Related]

  • 33. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.
    Frémeaux-Bacchi V, Miller EC, Liszewski MK, Strain L, Blouin J, Brown AL, Moghal N, Kaplan BS, Weiss RA, Lhotta K, Kapur G, Mattoo T, Nivet H, Wong W, Gie S, Hurault de Ligny B, Fischbach M, Gupta R, Hauhart R, Meunier V, Loirat C, Dragon-Durey MA, Fridman WH, Janssen BJ, Goodship TH, Atkinson JP.
    Blood; 2008 Dec 15; 112(13):4948-52. PubMed ID: 18796626
    [Abstract] [Full Text] [Related]

  • 34. Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome.
    Goicoechea de Jorge E, Tortajada A, García SP, Gastoldi S, Merinero HM, García-Fernández J, Arjona E, Cao M, Remuzzi G, Noris M, Rodríguez de Córdoba S.
    J Am Soc Nephrol; 2018 Jan 15; 29(1):240-249. PubMed ID: 28993505
    [Abstract] [Full Text] [Related]

  • 35. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.
    Provaznikova D, Rittich S, Malina M, Seeman T, Marinov I, Riedl M, Hrachovinova I.
    Pediatr Nephrol; 2012 Jan 15; 27(1):73-81. PubMed ID: 21706448
    [Abstract] [Full Text] [Related]

  • 36. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).
    Westra D, Volokhina E, van der Heijden E, Vos A, Huigen M, Jansen J, van Kaauwen E, van der Velden T, van de Kar N, van den Heuvel L.
    Nephrol Dial Transplant; 2010 Jul 15; 25(7):2195-202. PubMed ID: 20106822
    [Abstract] [Full Text] [Related]

  • 37. Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS.
    Ermini L, Goodship TH, Strain L, Weale ME, Sacks SH, Cordell HJ, Fremeaux-Bacchi V, Sheerin NS.
    Mol Immunol; 2012 Jan 15; 49(4):640-8. PubMed ID: 22153652
    [Abstract] [Full Text] [Related]

  • 38. First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis.
    Szarvas N, Szilágyi Á, Tasic V, Nushi-Stavileci V, Sofijanova A, Gucev Z, Szabó M, Szabó A, Szeifert L, Reusz G, Rusai K, Arbeiter K, Müller T, Prohászka Z.
    Ital J Pediatr; 2014 Dec 11; 40():101. PubMed ID: 25496981
    [Abstract] [Full Text] [Related]

  • 39. Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes.
    Peyvandi F, Rossio R, Ferrari B, Lotta LA, Pontiggia S, Ghiringhelli Borsa N, Pizzuti M, Donadelli R, Piras R, Cugno M, Noris M.
    J Thromb Haemost; 2016 Feb 11; 14(2):340-5. PubMed ID: 26613809
    [Abstract] [Full Text] [Related]

  • 40. Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome.
    Zhang Y, Kremsdorf RA, Sperati CJ, Henriksen KJ, Mori M, Goodfellow RX, Pitcher GR, Benson CL, Borsa NG, Taylor RP, Nester CM, Smith RJH.
    Kidney Int; 2020 Nov 11; 98(5):1265-1274. PubMed ID: 32540405
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.